e-learning
resources
Berlin 2001
Monday 24.09.2001
Infection, vaccination, exacerbation and quality of life in asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment of asthma exacerbations managed in primary care in Spain
J. Molina, E. Calvo, E. Cimas, E. Hernandez, M. A. Lobo, M. A. Llauger, P. Martin, K. Naberan, L. Olmo, J. I. Sanchez (Madrid, Spain)
Source:
Annual Congress 2001 - Infection, vaccination, exacerbation and quality of life in asthma
Session:
Infection, vaccination, exacerbation and quality of life in asthma
Session type:
Thematic Poster Session
Number:
1620
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Molina, E. Calvo, E. Cimas, E. Hernandez, M. A. Lobo, M. A. Llauger, P. Martin, K. Naberan, L. Olmo, J. I. Sanchez (Madrid, Spain). Treatment of asthma exacerbations managed in primary care in Spain. Eur Respir J 2001; 16: Suppl. 31, 1620
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Cost of asthma exacerbations managed in primary care in Spain
Source: Eur Respir J 2001; 18: Suppl. 33, 329s
Year: 2001
Economic implications of treatment pathways of asthma exacerbations managed in primary care in Spain
Source: Eur Respir J 2001; 18: Suppl. 33, 235s
Year: 2001
Manner of treatment and costs of COPD exacerbations in secondary medical care in Poland
Source: Eur Respir J 2007; 30: Suppl. 51, 194s
Year: 2007
COPD exacerbation and primary care physicians
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009
Provision of care for acute COPD in UK hospitals: survey of acute NIV provision for COPD exacerbations
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Can the organisation of COPD care in primary health care centres help preventing exacerbations in COPD patients?
Source: Annual Congress 2012 - Effectiveness of respiratory disease management in primary care
Year: 2012
How are we managing our asthmatic patients? Asthma diagnosis and treatment in an urban primary care practice
Source: Eur Respir J 2004; 24: Suppl. 48, 85s
Year: 2004
Reason for non-compliance to inhaled medications among adult patients of asthma and COPD attending outpatient department in a tertiary care hospital
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Diagnosis and long-term treatment of patients with asthma in primary health care facilities in Saint-Petersburg, Russia
Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care
Year: 2009
Home care in patients hospitalized for exacerbation of COPD
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Reducing inappropriate high dose ICS prescribing for COPD in primary care using respiratory integrated care virtual clinics
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
The impact of implementing a COPD care bundle on the delivery of care to patients admitted with an acute exacerbation of COPD
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Integrated care in patients with advanced COPD prevent exacerbations
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Differences in managing COPD exacerbations in primary and secondary care
Source: Eur Respir J 2007; 30: Suppl. 51, 128s
Year: 2007
Recommendation of care at discharge after hospital admitted COPD exacerbation: how integrated is COPD care in Europe?
Source: Annual Congress 2013 –Optimising health care for COPD across Europe
Year: 2013
Budesonide/formoterol for the treatment of COPD exacerbations in the primary healthcare setting
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Provision of self-management plans for treatment of COPD exacerbations reduce hospital admissions
Source: Eur Respir J 2007; 30: Suppl. 51, 569s
Year: 2007
One year with certified asthma and COPD-clinics in Skåne, Sweden
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015
Preventative care and home treatment in patients at risk of hospitalisation due to exacerbation of COPD.
Source: International Congress 2018 – The many facets of respiratory nursing
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept